EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE
|
Back to Search Results |
|
Model Number 11500A25 |
Device Problems
Gradient Increase (1270); Insufficient Information (3190)
|
Patient Problems
Chest Pain (1776); Dyspnea (1816); Fatigue (1849); Swelling/ Edema (4577); Insufficient Information (4580)
|
Event Date 08/10/2023 |
Event Type
Injury
|
Event Description
|
It was reported that a patient with a 25mm 11500a valve in the aortic position, underwent a valve-in-valve procedure after an implant duration of 3 years, 9 months due to unknown reason.The tavr was performed with a 26mm 9750tfx transcatheter valve.
|
|
Manufacturer Narrative
|
H10: additional manufacturer narrative: the investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.
|
|
Manufacturer Narrative
|
H10: additional manufacturer narrative: the investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.
|
|
Event Description
|
It was reported that a patient with a 25mm 11500a valve in the aortic position, underwent a valve-in-valve procedure after an implant duration of 3 years, 9 months due to severe stenosis.The patient presented with dyspnea, intermittent chest pain, fatigue, le edema.The tavr was performed with a 26mm 9750tfx transcatheter valve.Per medical records, patient started on xarelto for possible halt.Echo at the time showed severe stenosis or obstruction.Chest pain has since resolved but has extreme fatigue and le edema.Indication for redo-avr approximately 4 months later was stenosis.
|
|
Manufacturer Narrative
|
H10: additional manufacturer narrative: the device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.Stenosis, which develops progressively over time, can be due to a number of issues.Additionally, there can be a number of potential known and unknown patient-related contributing factors.Structural valve deterioration (svd) is the most common reason for bioprosthesis explant and encompasses multiple failure modes, including calcification, noncalcific degeneration, dehiscence, cusp thickening or fibrosis, or a combination of these.Such failure modes, occurring singularly or concomitantly, may contribute to stenosis and/or regurgitation.Alternatively, non-structural valve dysfunction (nsvd) may also play a role in the development of valvular stenosis.Stenosis is most commonly related to patient factors and is not usually an indication of a device malfunction.The most likely cause is patient factors, including coronary artery disease (cad) and hyperlipidemia (hld).
|
|
Search Alerts/Recalls
|
|
|